Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FB2001 Aerosol for COVID-19 PEP
NCT05415241Phase 2Unknown
- Sponsor
- Ruijin Hospital
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Compound 7b in coronavirus disease 2019 (COVID-19), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
Compound 7b
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05415241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415241.